ADRB2 and breast carcinoma: In another study, β2AR expression was associated with lower disease-free survival and higher lymph node metastasis rates in a small cohort of HER2+ breast cancer patients [121], but opposing results were obtained in another small cohort of HER2+ patients where it was associated with improved disease-free survival [124].